Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$692,395.00
Apr 1, 2014
Epigenetic, molecular and cellular effects of folic acid supplementation in the susceptible periods of the life cycle
$240,019.00
Apr 1, 2014
Teens Taking Charge: A Pilot Randomized Controlled Trial of a Self-Management and Transitional Care Program for Youth with Cancer
$711,773.00
Apr 1, 2014
Neuroendocrine regulation of adult neuroplasticity and behaviour
$100,000.00
Apr 1, 2014
Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
$44,976.00
Apr 1, 2014
Supporting shared decisions in pediatric otolaryngology (Phase 1): Needs assessment and decision aid development
$159,756.00
Apr 1, 2014
Évaluation du potentiel thérapeutique in vivo d'un nouvel inhibiteur de la stéroïde sulfatase combinant des propriétés ostéogénique et antiestrogénique pour le traitement des cancers du sein et de la prostate
$914,350.00
Apr 1, 2014
Advanced therapeutic strategies for ex vivo repair of lungs for transplantation
$205,815.00
Apr 1, 2014
Leaving It All Up To Us-Experiences of Informal Metis Caregivers
$1,191,865.00
Apr 1, 2014
Epigenomics of major depressive disorder: dissecting environmental, heritable, and stochastic contributions
$63,008.00
Apr 1, 2014
Frequent ventricular premature contractions in heart failure: prevalence and prognosis